Quality control strains used in susceptibility testing of Campylobacter spp.

被引：25

作者：

Hakanen, A

Huovinen, P

Kotilainen, P

Siitonen, A

Jousimies-Somer, H

机构：

[1] Natl Publ Hlth Inst, Antimicrobial Res Lab, Turku 20521, Finland

[2] Univ Turin, Cent Hosp, Dept Med, Turku, Finland

[3] Natl Publ, Hlth Inst, Anaerobe Ref Lab, Helsinki, Finland

[4] Natl Publ, Hlth Inst, Lab Enter Pathogens, Helsinki, Finland

来源：

JOURNAL OF CLINICAL MICROBIOLOGY | 2002年 / 40卷 / 07期

关键词：

D O I：

10.1128/JCM.40.7.2705-2706.2002

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

引用

页码：2705 / 2706

页数：2

共 5 条

[1]

[Anonymous], PERF STAND ANT SUSC

[2] In vitro activity of the new ketolide telithromycin compared with those of macrolides against Streptococcus pyogenes:: Influences of resistance mechanisms and methodological factors [J].

Bemer-Melchior, P ;

Juvin, ME ;

Tassin, S ;

Bryskier, A ;

Schito, GC ;

Drugeon, HB .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (11) :2999-3002

[3] Quinolone and macrolide resistance in Campylobacter jejuni and C-coli:: Resistance mechanisms and trends in human isolates [J].

Engberg, J ;

Aarestrup, FM ;

Taylor, DE ;

Gerner-Smidt, P ;

Nachamkin, I .

EMERGING INFECTIOUS DISEASES, 2001, 7 (01) :24-34

[4] EVOLUTION OF SUSCEPTIBILITIES OF CAMPYLOBACTER SPP TO QUINOLONES AND MACROLIDES [J].

SANCHEZ, R ;

FERNANDEZBACA, V ;

DIAZ, MD ;

MUNOZ, P ;

RODRIGUEZCREIXEMS, M ;

BOUZA, E .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (09) :1879-1882

[5] Quinolone-resistant Campylobacter jejuni infections in Minnesota, 1992-1998 [J].

Smith, KE ;

Besser, JM ;

Hedberg, CW ;

Leano, FT ;

Bender, JB ;

Wicklund, JH ;

Johnson, BP ;

Moore, KA ;

Osterholm, MT .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (20) :1525-1532

← 1 →